Cargando…

Allergen challenge tests in allergen immunotherapy: State of the art

Introduction: Treatment effects in allergen immunotherapy (AIT) studies are based on symptomatic improvement, and evaluations of naturally exposed patients do often show weak efficacy. Allergen challenge tests, such as conjunctival (CAC), nasal (NAC), or bronchial (BAC) challenge tests, or challenge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zieglmayer, Petra, Zieglmayer, René, Lemell, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dustri-Verlag Dr. Karl Feistle 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012425/ https://www.ncbi.nlm.nih.gov/pubmed/36925996 http://dx.doi.org/10.5414/ALX02322E

Ejemplares similares

Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis
por: Jordakieva, Galateja, et al.
Publicado: (2017)

Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy
por: Pfaar, O., et al.
Publicado: (2020)

Effects of Nasal Corticosteroids on Boosts of Systemic Allergen-Specific IgE Production Induced by Nasal Allergen Exposure
por: Egger, Cornelia, et al.
Publicado: (2015)

Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot study
por: Roth-Walter, Franziska, et al.
Publicado: (2018)

Peripheral Erythrocytes Decrease upon Specific Respiratory Challenge with Grass Pollen Allergen in Sensitized Mice and in Human Subjects
por: Jordakieva, Galateja, et al.
Publicado: (2014)

IgE Epitopes of the House Dust Mite Allergen Der p 7 Are Mainly Discontinuous and Conformational
por: Curin, Mirela, et al.
Publicado: (2021)

Possible effect of landscape design on IgE recognition profiles of two generations revealed with micro‐arrayed allergens
por: Garib, V., et al.
Publicado: (2017)

Dogmas, challenges, and promises in phase III allergen immunotherapy studies()
por: De Kam, Pieter-Jan, et al.
Publicado: (2021)

Recombinant allergens for immunotherapy: state of the art
por: Zhernov, Yury, et al.
Publicado: (2019)

Clinical endpoints in allergen immunotherapy: State of the art 2022
por: Gerth van Wijk, Roy, et al.
Publicado: (2023)

Fast effectiveness of a solubilized low‐dose budesonide nasal spray in allergic rhinitis
por: Zieglmayer, Petra, et al.
Publicado: (2020)

A meta‐analysis on allergen‐specific immunotherapy using MCT(®) (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis
por: Becker, Sven, et al.
Publicado: (2021)

Nanoparticle–allergen complexes for allergen immunotherapy
por: Di Felice, Gabriella, et al.
Publicado: (2017)

Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32
por: Tulaeva, Inna, et al.
Publicado: (2020)

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
por: Zieglmayer, Petra, et al.
Publicado: (2016)

Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen
por: Resch, Yvonne, et al.
Publicado: (2016)

Grand Challenges in Allergen Immunotherapy
por: Cox, Linda
Publicado: (2021)

Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens
por: Akdis, Cezmi A, et al.
Publicado: (2015)

Allergen-specific immunotherapy
por: Moote, William, et al.
Publicado: (2011)

Allergen immunotherapy in pregnancy
por: Oykhman, Paul, et al.
Publicado: (2015)

Allergen-specific immunotherapy
por: Moote, William, et al.
Publicado: (2018)

Allergen Immunotherapy in Asthma
por: Nakagome, Kazuyuki, et al.
Publicado: (2021)

Immunology of allergen immunotherapy
por: Rahman, Rifat S, et al.
Publicado: (2022)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014)

Allergen immunotherapy
por: Crisafulli, Giuseppe, et al.
Publicado: (2014)

IgE reactivity patterns in Asian and central European cockroach-sensitized patients reveal differences in primary sensitizing allergen sources
por: Mittermann, Irene, et al.
Publicado: (2022)

Current state-of-the-art for allergen immunoassays
por: Ulberth, Franz
Publicado: (2011)

Pru p 3, a marker allergen for lipid transfer protein sensitization also in Central Europe
por: Mothes‐Luksch, N., et al.
Publicado: (2017)

KAAACI Guidelines for Allergen Immunotherapy
por: Lee, Hwa Young, et al.
Publicado: (2023)

Mechanisms of allergen-specific immunotherapy
por: Fujita, Hiroyuki, et al.
Publicado: (2012)

Patient’s compliance with allergen immunotherapy
por: Incorvaia, Cristoforo, et al.
Publicado: (2008)

New treatments for allergen immunotherapy
por: Akdis, Mübeccel
Publicado: (2014)

Aluminium in Allergies and Allergen immunotherapy
por: Jensen-Jarolim, Erika
Publicado: (2015)

Use of biologics in allergen immunotherapy
por: Pfützner, Wolfgang, et al.
Publicado: (2021)

Digital health for allergen immunotherapy
por: Dramburg, Stephanie, et al.
Publicado: (2022)

Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season
por: Mösges, Ralph, et al.
Publicado: (2019)

Allergen immunotherapy phase II trials: Challenges in dose finding
por: Kleine-Tebbe, J., et al.
Publicado: (2019)

The conjunctival allergen provocation test and the nasal allergen provocation test as specific alternatives to the oral food challenge
por: Krzych-Fałta, Edyta
Publicado: (2021)

Immunotherapy with Allergen Peptides
por: Larché, Mark
Publicado: (2007)

Allergen Immunotherapy: Past, Present, and Future
por: Jutel, Marek, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l14pvcsr2u0hkdj85o8523re51